Search Tag: Gadolinium Deposition

IMAGING Management

2018 20 Mar

Radiologists do not routinely report gadolinium deposition findings Brain deposition of gadolinium following the administration of gadolinium-based contrast agents (GBCAs) was initially reported in 2014, although its potential clinical implications remain unclear. Researchers have conducted an international survey of radiologists to determine their...Read more

IMAGING Management

2017 27 Jun

Minute traces of gadolinium, the contrast agent used to enhance MR images, are often retained in the brain tissue of patients years after undergoing MRI. New research suggests however that gadolinium retention may be more widespread and may be present in many more, or possibly all, patients exposed to gadolinium-based contrast agents. The findings,...Read more